Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -0.8123
March 31, 2026 -0.7867
December 31, 2025 -0.8187
September 30, 2025 -0.838
June 30, 2025 -0.8295
March 31, 2025 -0.7916
December 31, 2024 -0.8158
September 30, 2024 -0.8111
June 30, 2024 -0.7863
March 31, 2024 -0.7875
December 31, 2023 -0.8099
September 30, 2023 -0.7593
June 30, 2023 -0.7854
March 31, 2023 -0.8289
December 31, 2022 -0.7058
September 30, 2022 -0.6297
June 30, 2022 -0.6265
March 31, 2022 -0.7104
December 31, 2021 -0.7109
September 30, 2021 -0.9663
June 30, 2021 -1.562
March 31, 2021 -1.659
December 31, 2020 -0.4584
September 30, 2020 -0.3829
June 30, 2020 -0.5875
Date Value
March 31, 2020 -0.3694
December 31, 2019 -0.2713
September 30, 2019 -0.2853
June 30, 2019 -0.3263
March 31, 2019 -0.3372
December 31, 2018 -0.3458
September 30, 2018 -0.4137
June 30, 2018 -0.8849
March 31, 2018 -2.486
December 31, 2017 -0.4627
September 30, 2017 -0.3787
June 30, 2017 -0.4516
March 31, 2017 -0.418
December 31, 2016 -0.488
September 30, 2016 -0.524
June 30, 2016 -0.3978
March 31, 2016 -0.3723
December 31, 2015 -0.3997
September 30, 2015 -0.2527
June 30, 2015 -0.2986
March 31, 2015 -0.0128
December 31, 2014 -0.0349
September 30, 2014 -0.0124
June 30, 2014 -0.0108
March 31, 2014 -0.0645

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
MedMira, Inc. -0.7106
VentriPoint Diagnostics Ltd. -0.632
Theralase Technologies, Inc. 0.0217
Profound Medical Corp. 0.1482
VVT Med, Inc. -0.6369

Debt to Equity Ratio Related Metrics